Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma
暂无分享,去创建一个
A. Oriol | P. Moreau | M. Macro | J. San-Miguel | J. Bladé | J. Lahuerta | B. Arnulf | M. Hernandez | M. Mateos | M. Attal | K. Belhadj | C. Hulin | D. Caillot | Guang Chen | A. Sureda | R. Ríos | B. Hébraud | M. Blanchard | Laura Rosinol Dachs | Anne-Laurène Colin | M. B. Garelik | Laura Rosiñol Dachs